Literature DB >> 8862332

The incidence of hepatitis B infection in Australia: an epidemiological review.

J M Kaldor1, A J Plant, S C Thompson, H Longbottom, J Rowbottom.   

Abstract

Hepatitis B virus (HBV) infection in Australia remains a significant problem despite the availability of an inexpensive vaccine. National information about incidence, prevalence, morbidity and the extent of vaccine coverage is incomplete; improved surveillance would allow for better targeting and evaluation of prevention activities. Our estimates indicate that 75%-90% of cases of vertical transmission of HBV are preventable through vaccination of newborns whose mothers are carriers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862332     DOI: 10.5694/j.1326-5377.1996.tb124993.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  2 in total

1.  Cost-effectiveness analysis of lamivudine for the treatment of chronic hepatitis B.

Authors:  S J Crowley; D Tognarini; P V Desmond; M Lees
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 2.  Chronic hepatitis B prevalence among Aboriginal and Torres Strait Islander Australians since universal vaccination: a systematic review and meta-analysis.

Authors:  Simon Graham; Rebecca J Guy; Benjamin Cowie; Handan C Wand; Basil Donovan; Snehal P Akre; James S Ward
Journal:  BMC Infect Dis       Date:  2013-08-31       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.